ea0090rc11.1 | Rapid Communications 11: Late Breaking | ECE2023
Karov Ruti
, Eldor Roy
, Kolitz Tamara
, Ehrenwald Michal
, Feigin Eugene
, Greenman Yona
Introduction: Severe insulinopenic diabetes (SID) is a rare complication of treatment with immune checkpoint inhibitors (ICPI). We describe herein the clinical characteristics, natural history and potential predictors of SID in cancer patients treated with ICPI.Methods: We identified and retrospectively retrieved pertinent clinical data of all patients who presented with new onset SID following treatment with ICPI between 2015 and 2022 at the Tel Aviv-So...